PDC and COVID-19: In addition, no significant difference was found regarding the proportion of proliferating cells (Supplementary Fig. S1b), megakaryocytes (Supplementary Fig. S1c), or pDC (Supplementary Fig. S1d) between COVID-19 patients and HC.